Mayne Pharma Group Ltd has released a press release.
Mayne Pharma recipient of $4.8m Federal Government Grant
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Mayne Pharma Group Limited - NON-EXECUTIVE DIRECTOR APPOINTMENT
- 22/03/2022 Non Executive Director Appointment
- Mayne Pharma reports 1HFY22 results
- 2022 Half Year Investor Presentation
- Mayne Pharma expands US dermatology portfolio
Later from Mayne Pharma
- Wilsons investor conference presentation
- New Chief Financial Officer appointment
- Mayne Pharma Group Limited and Mithra Pharmaceuticals - NEXTSTELLIS ORAL CONTRACEPTIVE NOW AVAILABLE IN AUSTRALIA
- Mayne Pharma and GoodRx announce new initiative to increase awareness of NEXTSTELLIS and expand access to birth control
- Mayne Pharma and Mithra announce FDA approval of Haloette, a generic version of Nuvaring
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma